The short answer
A fatal bleeding case involved dabigatran and a ginger/cinnamon drink, but it does not establish the risk of ginger root powder alone. It also did not measure drug concentrations. Review concentrated ginger products before combining them with dabigatran etexilate; a timing gap is not a proven safeguard.
What this answer covers
Oral Zingiber Officinale (Ginger) Root Powder with adult oral dabigatran etexilate. Powder, extracts, food portions and the reported mixed ginger/cinnamon decoction are not interchangeable.
- Supplement or preparation
- Ginger root powder
- Medication ingredient
- dabigatran etexilate
What does the bleeding report tell us?
An 80-year-old man who had taken dabigatran for four years developed fatal gastrointestinal bleeding after three days of a boiled ginger/cinnamon mixture. The drink was 200 mL twice daily, but the amounts of each herb were not established. Because two herbs were combined, the report cannot isolate ginger or define a safe powder dose.
Does ginger increase the medicine’s blood level?
The case did not measure active dabigatran levels or absorption of its prodrug. P-glycoprotein inhibition was a suggested explanation, not a demonstrated patient-level mechanism. A small healthy-volunteer ginger study involving warfarin found no significant effect, but that different medicine cannot establish compatibility here.
Which ginger product is being considered?
This page concerns a root-powder entry, so evidence from a tea or concentrated extract must be kept separate. Record the dose, formulation and any other herbs. Ordinary food seasoning is a different exposure from repeated concentrated supplements or a mixed medicinal drink.
What should I do before using it?
Dabigatran etexilate is the swallowed prodrug. The body converts it to dabigatran, which directly inhibits thrombin. Continue dabigatran etexilate as prescribed and review the supplement with the treating team, including other medicines that increase bleeding risk. There is no tested time gap that neutralizes the uncertainty. Report unusual bleeding promptly and obtain urgent help for heavy bleeding, vomiting blood or black stools.
Evidence and practical considerations
Side effects & toxicity
A fatal bleeding case involved dabigatran and a ginger/cinnamon drink, but it does not establish the risk of ginger root powder alone. It also did not measure drug concentrations. Review concentrated ginger products before combining them with dabigatran etexilate; a timing gap is not a proven safeguard.
- Exact scope
- Oral Zingiber Officinale (Ginger) Root Powder with adult oral dabigatran etexilate. Powder, extracts, food portions and the reported mixed ginger/cinnamon decoction are not interchangeable. with adult oral dabigatran etexilate mesylate capsules; active dabigatran produced after absorption
- Medication form and route
- adult oral dabigatran etexilate mesylate capsules; active dabigatran produced after absorption
- Timing or duration
- Concurrent oral use. Source-specific durations are recorded in the evidence entries; no unstudied duration threshold or separation schedule is inferred.
What remains uncertain
- Mixed ginger/cinnamon case does not isolate ginger root powder, measure drug exposure or prove the proposed P-gp mechanism. Warfarin study is indirect; apixaban transfer adds another untested bridge.
Factors that may matter: Exact supplement preparation, dose and additional ingredients; Kidney function, age, bleeding history and other antiplatelet or anticoagulant medicines; Current medication formulation and recent supplement start or stop.
Read the supporting source summaries
Source 1: current U.S. regulatory prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients receiving oral dabigatran etexilate capsules.
P-gp induction reduces active dabigatran exposure. P-gp inhibition and impaired renal function increase exposure. Capsules must be swallowed intact. RE-LY trough concentrations were not appreciably changed by concomitant PPIs or H2 blockers.
How this applies: Establishes the exact medicine’s mechanism, baseline bleeding precautions and formulation/transport limitations; it does not establish this supplement-specific interaction. Exact scope: Oral Zingiber Officinale (Ginger) Root Powder with adult oral dabigatran etexilate. Powder, extracts, food portions and the reported mixed ginger/cinnamon decoction are not interchangeable.
Named medicine dose adjustments cannot be extrapolated to untested herbs. Label silence about a supplement does not prove compatibility. Capsule results must not be generalized to every formulation.
Source 2: peer-reviewed original research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 12 healthy men in a randomized open-label crossover study.
Neither tested herb significantly changed warfarin clearance, INR response or platelet aggregation.
How this applies: Applied only as indirect context; the study or guidance did not establish an interaction with this exact direct oral anticoagulant. It is interpreted only alongside the current dabigatran etexilate label; any source using warfarin or no anticoagulant is indirect for this pair. Exact scope: Oral Zingiber Officinale (Ginger) Root Powder with adult oral dabigatran etexilate. Powder, extracts, food portions and the reported mixed ginger/cinnamon decoction are not interchangeable.
Healthy volunteers, single warfarin exposure and short follow-up; precise product strengths are not provided in the retrieved abstract. Does not establish safety during chronic anticoagulation or for every root powder or extract.
Source 3: original human case report
europepmc.org · Source check Sep 10, 2026
Population: 80-year-old man taking dabigatran 110 mg twice daily for four years; reported eGFR 90 mL/min/1.73 m2.
Fatal diffuse upper gastrointestinal bleeding occurred despite transfusion and idarucizumab.
How this applies: Dabigatran etexilate oral prodrug is the prescribed medicine, but the exposure was a mixed ginger/cinnamon drink, not isolated root powder; no measured concentration or absorption change. Exact scope: Oral Zingiber Officinale (Ginger) Root Powder with adult oral dabigatran etexilate. Powder, extracts, food portions and the reported mixed ginger/cinnamon decoction are not interchangeable.
Two herbs taken together, no isolated ginger-root-powder exposure, no dabigatran concentration measurement and no rechallenge. The authors’ P-gp explanation is a hypothesis; the case does not establish increased prodrug absorption.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Current labels and targeted original sources assessed; all current available claims adjudicated and consumer article prepared. Uncertainty and indirect evidence retained. Clinical sign-off not recorded. | |
| Research summary published |
Article revision: ba58a64f42d4db30
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.